# COVID-19 Antibody Responses in Cystic Fibrosis

> **NCT04992234** · — · COMPLETED · sponsor: **Vastra Gotaland Region** · enrollment: 113 (actual)

## Conditions studied

- Cystic Fibrosis
- Covid19

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04992234
- **Lead sponsor:** Vastra Gotaland Region
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-31
- **Primary completion:** 2024-07-22
- **Final completion:** 2025-04-14
- **Target enrollment:** 113 (ACTUAL)
- **Last updated:** 2026-01-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04992234

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04992234, "COVID-19 Antibody Responses in Cystic Fibrosis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04992234. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*